Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors

Condition:   Malignant Tumors Intervention:   Biological: EBV mRNA vaccine Sponsor:   West China Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials